{"title":"Management of Psuedomonas Keratitis: a review article","authors":"Mouna M. AlSaad","doi":"10.3823/813","DOIUrl":null,"url":null,"abstract":"Bacterial keratitis can lead to severe vision loss and corneal scarring, and possibly perforation. Early and appropriate management is a key factor in decreasing and preventing complication. Pubmed and Medline were searched for articles related to Pseudomonas keratitis between year 2000 and 2017 to get current guidelines about the management of Pseudomonas keratitis. These articles are reviewed in this article and information related to management is summarized. The most used agents to treat Pseudomonas are either aminoglycosides (usually gentamicin) fortified with a cephalosporin or mono therapy with a fluoroquinolones usually ciprofloxacin. In most areas, most strains of Pseudomonas were susceptible to ciprofloxacin. The role of topical steroids is discussed, as well as, available options for treatment of multidrug resistant Pseudomonas species. Management of Psuedomonas keratitis: A review article Mouna Mohamad Al Saad1 1 Faculty of Medicine, Department of special surgery/Division Ophthalmology. The University of Jordan, Amman, Jordan. Contact information: Dr. Mouna Mohamad Al Saad. m.alsaad@ju.edu.jo.","PeriodicalId":22518,"journal":{"name":"The International Arabic Journal of Antimicrobial Agents","volume":"2 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The International Arabic Journal of Antimicrobial Agents","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3823/813","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Bacterial keratitis can lead to severe vision loss and corneal scarring, and possibly perforation. Early and appropriate management is a key factor in decreasing and preventing complication. Pubmed and Medline were searched for articles related to Pseudomonas keratitis between year 2000 and 2017 to get current guidelines about the management of Pseudomonas keratitis. These articles are reviewed in this article and information related to management is summarized. The most used agents to treat Pseudomonas are either aminoglycosides (usually gentamicin) fortified with a cephalosporin or mono therapy with a fluoroquinolones usually ciprofloxacin. In most areas, most strains of Pseudomonas were susceptible to ciprofloxacin. The role of topical steroids is discussed, as well as, available options for treatment of multidrug resistant Pseudomonas species. Management of Psuedomonas keratitis: A review article Mouna Mohamad Al Saad1 1 Faculty of Medicine, Department of special surgery/Division Ophthalmology. The University of Jordan, Amman, Jordan. Contact information: Dr. Mouna Mohamad Al Saad. m.alsaad@ju.edu.jo.
细菌性角膜炎可导致严重的视力丧失和角膜瘢痕,并可能穿孔。早期适当的治疗是减少和预防并发症的关键因素。在Pubmed和Medline检索2000年至2017年间与假单胞菌角膜炎相关的文章,以获得假单胞菌角膜炎管理的最新指南。本文对这些文章进行了回顾,并对与管理相关的信息进行了总结。治疗假单胞菌最常用的药物是氨基糖苷类药物(通常是庆大霉素)加头孢菌素或氟喹诺酮类药物(通常是环丙沙星)的单药治疗。在大多数地区,大多数假单胞菌对环丙沙星敏感。讨论了局部类固醇的作用,以及治疗多重耐药假单胞菌的可用选择。假单胞菌性角膜炎的治疗:一篇综述文章。Mouna Mohamad Al saad[11]医学院特殊外科/眼科。约旦大学,安曼,约旦。联系方式:Mouna Mohamad Al Saad博士。m.alsaad@ju.edu.jo。